OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and Correlates of Long COVID Symptoms Among US Adults
Roy H. Perlis, Mauricio Santillana, Katherine Ognyanova, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2238804-e2238804
Open Access | Times Cited: 313

Showing 1-25 of 313 citing articles:

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 152

Long COVID: a clinical update
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 85

The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
Kamlesh Khunti, Vanita R. Aroda, Pablo Aschner, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 12, pp. 890-900
Open Access | Times Cited: 73

Factors Associated With Long COVID Symptoms in an Online Cohort Study
Matthew S. Durstenfeld, Michael J. Peluso, Noah D. Peyser, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 2
Open Access | Times Cited: 70

Association of Post–COVID-19 Condition Symptoms and Employment Status
Roy H. Perlis, Kristin Lunz Trujillo, Alauna Safarpour, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2256152-e2256152
Open Access | Times Cited: 70

Cellular and molecular biomarkers of long COVID: a scoping review
Estefanía Espín, Chengliang Yang, Casey P. Shannon, et al.
EBioMedicine (2023) Vol. 91, pp. 104552-104552
Open Access | Times Cited: 66

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection
Stephanie A Richard, Simon Pollett, Anthony C Fries, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2251360-e2251360
Open Access | Times Cited: 65

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65

Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update
Sizhen Su, Yi‐Miao Zhao, Na Zeng, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4056-4069
Closed Access | Times Cited: 62

Post COVID-19 condition, work ability and occupational changes in a population-based cohort
Philipp Kerksieck, Tala Ballouz, Sarah R. Haile, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100671-100671
Open Access | Times Cited: 57

Communication of COVID-19 Misinformation on Social Media by Physicians in the US
Sahana Sule, Marisa C. DaCosta, Erin DeCou, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2328928-e2328928
Open Access | Times Cited: 56

A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China
Jianpeng Cai, Ke Lin, Haocheng Zhang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 51

Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
Lourdes Mateu, Cristian Tebé, Cora Loste, et al.
The Lancet Regional Health - Europe (2023) Vol. 33, pp. 100724-100724
Open Access | Times Cited: 51

Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study
Christian R. Kahlert, Carol Strahm, Sabine Güsewell, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 2, pp. 194-202
Open Access | Times Cited: 46

The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research
Alexandre R. Marra, Takaaki Kobayashi, Gustavo Yano Callado, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 45

Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis
Zoe Marjenberg, Sean X. Leng, Carlo Tascini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 43

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23

Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: prospective cohort study
Yoonjung Kim, Sohyun Bae, Hyun‐Ha Chang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 20

Cognitive Symptoms of Post–COVID-19 Condition and Daily Functioning
Abhishek Jaywant, Faith M. Gunning, Lauren E. Oberlin, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e2356098-e2356098
Open Access | Times Cited: 16

Interventions for the management of post-COVID-19 condition (long COVID): protocol for a living systematic review and network meta-analysis
Dena Zeraatkar, King‐Hwa Ling, Sarah Kirsh, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e086407-e086407
Open Access | Times Cited: 2

What is really ‘Long COVID’?
Sándor Szabó, Оksana Zayachkivska, Azhar Hussain, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 551-557
Open Access | Times Cited: 39

The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June–July 2022
Saba A Qasmieh, McKaylee Robertson, Chloe A. Teasdale, et al.
Preventive Medicine (2023) Vol. 169, pp. 107461-107461
Open Access | Times Cited: 34

Long COVID-19 Pathophysiology: What Do We Know So Far?
Nikolaos Tziolos, Πέτρος Ιωάννου, Stella Baliou, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2458-2458
Open Access | Times Cited: 34

An intersectional analysis of long COVID prevalence
Jennifer Cohen, Yana van der Meulen Rodgers
International Journal for Equity in Health (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 31

Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020–2022
Alexandre R. Marra, Vanderson de Souza Sampaio, Mina Cintho Ozahata, et al.
Infection Control and Hospital Epidemiology (2023) Vol. 44, Iss. 12, pp. 1972-1978
Closed Access | Times Cited: 30

Page 1 - Next Page

Scroll to top